| Ligand | Protein Symbol | Approved Name | Docking Scores |
Similarity Score |
Best Match | ||
|---|---|---|---|---|---|---|---|
| Model 1 | Model 2 | Model 3 | |||||
| Zanamivir | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -6.88 | -6.91 | -6.70 | 28.90% | CHEMBL442 |
| Laninamivir | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -6.40 | -7.10 | -6.60 | 30.99% | CHEMBL442 |
| Oseltamivir | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -6.88 | -6.93 | -7.31 | 28.52% | CHEMBL442 |
| Peramivir | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -7.23 | -8.52 | -7.67 | 27.27% | CHEMBL191460 |
| Baloxavir | 5HT1B_HUMAN | 5-hydroxytryptamine receptor 1B | -8.20 | -8.39 | -6.49 | 32.82% | CHEMBL225310 |
| Zanamivir | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -7.52 | -7.26 | N/A | 33.33% | CHEMBL514157 |
| Laninamivir | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -7.37 | -6.98 | N/A | 34.67% | CHEMBL473765 |
| Oseltamivir | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -7.42 | -8.06 | N/A | 51.90% | CHEMBL473765 |
| Peramivir | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -7.98 | -7.83 | N/A | 40.57% | CHEMBL80093 |
| Baloxavir | 5HT2A_HUMAN | 5-hydroxytryptamine receptor 2A | -7.58 | -2.22 | N/A | 30.97% | CHEMBL3954263 |
| Zanamivir | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -6.57 | -6.82 | -6.42 | 28.90% | CHEMBL442 |
| Laninamivir | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -6.25 | -7.13 | -6.87 | 30.99% | CHEMBL442 |
| Oseltamivir | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -6.58 | -6.85 | -6.77 | 38.05% | CHEMBL1123 |
| Peramivir | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -7.18 | -7.44 | -7.49 | 35.59% | CHEMBL1276947 |
| Baloxavir | 5HT2B_HUMAN | 5-hydroxytryptamine receptor 2B | -9.66 | -7.06 | -7.11 | 30.64% | CHEMBL56336 |
| Zanamivir | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -7.16 | -7.41 | N/A | 28.90% | CHEMBL442 |
| Laninamivir | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -7.34 | -7.58 | N/A | 30.99% | CHEMBL442 |
| Oseltamivir | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -6.99 | -7.71 | N/A | 38.05% | CHEMBL1123 |
| Peramivir | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -7.64 | -7.83 | N/A | 35.59% | CHEMBL1276947 |
| Baloxavir | 5HT2C_HUMAN | 5-hydroxytryptamine receptor 2C | -8.32 | -8.15 | N/A | 31.27% | CHEMBL216242 |
| Zanamivir | AA1R_HUMAN | adenosine A1 receptor | -5.91 | -6.56 | -6.22 | 30.47% | CHEMBL1234591 |
| Laninamivir | AA1R_HUMAN | adenosine A1 receptor | -6.02 | -6.34 | -6.61 | 31.91% | CHEMBL1950660 |
| Oseltamivir | AA1R_HUMAN | adenosine A1 receptor | -7.13 | -6.88 | -6.86 | 33.02% | CHEMBL608220 |
| Peramivir | AA1R_HUMAN | adenosine A1 receptor | -7.01 | -6.90 | -7.70 | 39.84% | CHEMBL329774 |
| Baloxavir | AA1R_HUMAN | adenosine A1 receptor | -8.76 | -9.72 | -4.58 | 32.66% | CHEMBL3942193 |
| Zanamivir | AA2AR_HUMAN | adenosine A2a receptor | -6.36 | -6.44 | -6.44 | 32.19% | CHEMBL129903 |
| Laninamivir | AA2AR_HUMAN | adenosine A2a receptor | -6.37 | -6.48 | -6.33 | 32.34% | CHEMBL3416777 |
| Oseltamivir | AA2AR_HUMAN | adenosine A2a receptor | -6.49 | -6.90 | -7.69 | 32.97% | CHEMBL3350613 |
| Peramivir | AA2AR_HUMAN | adenosine A2a receptor | -6.61 | -7.29 | -7.56 | 29.89% | CHEMBL376542 |
| Baloxavir | AA2AR_HUMAN | adenosine A2a receptor | -7.92 | -9.05 | -11.11 | 34.41% | CHEMBL3929822 |
| Zanamivir | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -8.26 | -7.28 | -8.39 | 31.44% | CHEMBL251077 |
| Laninamivir | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -8.33 | -8.33 | -8.56 | 31.91% | CHEMBL1222025 |
| Oseltamivir | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -7.98 | -7.76 | -8.43 | 43.06% | CHEMBL1080631 |
| Peramivir | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -8.48 | -8.47 | -8.38 | 41.76% | CHEMBL1783535 |
| Baloxavir | ACES_HUMAN | acetylcholinesterase (Cartwright blood group) | -9.78 | -8.79 | -8.03 | 33.06% | CHEMBL555247 |
| Zanamivir | ACE_HUMAN | angiotensin I converting enzyme | -7.33 | -6.79 | -6.50 | 32.66% | CHEMBL284898 |
| Laninamivir | ACE_HUMAN | angiotensin I converting enzyme | -7.33 | -7.33 | -6.44 | 32.54% | CHEMBL284898 |
| Oseltamivir | ACE_HUMAN | angiotensin I converting enzyme | -7.17 | -7.02 | -6.23 | 48.03% | CHEMBL1581 |
| Peramivir | ACE_HUMAN | angiotensin I converting enzyme | -8.18 | -7.55 | -6.99 | 46.36% | CHEMBL434617 |
| Baloxavir | ACE_HUMAN | angiotensin I converting enzyme | -9.68 | -8.01 | -2.33 | 29.27% | CHEMBL148616 |
| Zanamivir | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.53 | N/A | N/A | 25.30% | CHEMBL386114 |
| Laninamivir | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -5.97 | N/A | N/A | 23.13% | CHEMBL386114 |
| Oseltamivir | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -5.63 | N/A | N/A | 23.61% | CHEMBL386114 |
| Peramivir | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -5.96 | N/A | N/A | 24.73% | CHEMBL386114 |
| Baloxavir | ACHA9_HUMAN | cholinergic receptor nicotinic alpha 9 subunit | -6.97 | N/A | N/A | 21.97% | CHEMBL386114 |
| Zanamivir | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -4.47 | -6.46 | -5.48 | N/A | N/A |
| Laninamivir | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -3.90 | -5.43 | -5.88 | N/A | N/A |
| Oseltamivir | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -5.80 | -5.54 | -5.97 | N/A | N/A |
| Peramivir | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | -4.63 | -6.05 | -5.39 | N/A | N/A |
| Baloxavir | ACHB2_HUMAN | cholinergic receptor nicotinic beta 2 subunit | 12.56 | 9.23 | 1.38 | N/A | N/A |
| Zanamivir | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -7.15 | -0.03 | N/A | 34.34% | CHEMBL69452 |
| Laninamivir | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -6.99 | 1.56 | N/A | 34.13% | CHEMBL69452 |
| Oseltamivir | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -7.61 | -6.78 | N/A | 46.92% | CHEMBL182761 |
| Peramivir | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -8.73 | -2.14 | N/A | 47.95% | CHEMBL477542 |
| Baloxavir | ACM1_HUMAN | cholinergic receptor muscarinic 1 | -3.07 | 54.43 | N/A | 31.53% | CHEMBL3608415 |
| Zanamivir | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -7.20 | -6.26 | N/A | 31.10% | CHEMBL120080 |
| Laninamivir | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -6.38 | -6.46 | N/A | 31.05% | CHEMBL120080 |
| Oseltamivir | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -7.64 | -6.90 | N/A | 44.35% | CHEMBL313738 |
| Peramivir | ACM4_HUMAN | cholinergic receptor muscarinic 4 | -7.94 | -7.55 | N/A | 56.58% | CHEMBL479224 |
| Baloxavir | ACM4_HUMAN | cholinergic receptor muscarinic 4 | 0.08 | -4.88 | N/A | 29.70% | CHEMBL318995 |
| Zanamivir | ADRB2_HUMAN | adrenoceptor beta 2 | -7.31 | -7.49 | -7.87 | 32.98% | CHEMBL1569630 |
| Laninamivir | ADRB2_HUMAN | adrenoceptor beta 2 | -6.73 | -7.42 | -7.45 | 33.21% | CHEMBL1714856 |
| Oseltamivir | ADRB2_HUMAN | adrenoceptor beta 2 | -6.94 | -7.37 | -7.16 | 37.93% | CHEMBL1569630 |
| Peramivir | ADRB2_HUMAN | adrenoceptor beta 2 | -7.44 | -7.35 | -7.78 | 31.25% | CHEMBL1459608 |
| Baloxavir | ADRB2_HUMAN | adrenoceptor beta 2 | -5.88 | -7.31 | -6.85 | 33.11% | CHEMBL236040 |
| Zanamivir | AGTR2_HUMAN | angiotensin II receptor type 2 | -6.63 | -6.85 | -6.37 | 27.10% | CHEMBL3350599 |
| Laninamivir | AGTR2_HUMAN | angiotensin II receptor type 2 | -6.74 | -6.69 | -6.10 | 27.79% | CHEMBL507053 |
| Oseltamivir | AGTR2_HUMAN | angiotensin II receptor type 2 | -6.78 | -6.89 | -6.29 | 28.32% | CHEMBL3350599 |
| Peramivir | AGTR2_HUMAN | angiotensin II receptor type 2 | -6.97 | -6.86 | -6.58 | 32.85% | CHEMBL3350599 |
| Baloxavir | AGTR2_HUMAN | angiotensin II receptor type 2 | -9.08 | -9.60 | -8.98 | 31.34% | CHEMBL17487 |
| Zanamivir | ALDR_HUMAN | aldo-keto reductase family 1 member B | -6.51 | -5.56 | -5.47 | 31.28% | CHEMBL269550 |
| Laninamivir | ALDR_HUMAN | aldo-keto reductase family 1 member B | -5.86 | -5.72 | -5.89 | 31.56% | CHEMBL6828 |
| Oseltamivir | ALDR_HUMAN | aldo-keto reductase family 1 member B | -6.82 | -7.00 | -7.31 | 31.43% | CHEMBL6944 |
| Peramivir | ALDR_HUMAN | aldo-keto reductase family 1 member B | -6.78 | -6.10 | -6.19 | 24.42% | CHEMBL334830 |
| Baloxavir | ALDR_HUMAN | aldo-keto reductase family 1 member B | -9.22 | -7.72 | -7.84 | 32.23% | CHEMBL1946960 |
| Zanamivir | AMPN_HUMAN | alanyl aminopeptidase, membrane | -7.51 | -7.25 | -7.49 | 26.63% | CHEMBL28650 |
| Laninamivir | AMPN_HUMAN | alanyl aminopeptidase, membrane | -7.09 | -7.24 | -6.47 | 29.77% | CHEMBL2022238 |
| Oseltamivir | AMPN_HUMAN | alanyl aminopeptidase, membrane | -6.90 | -7.23 | -6.36 | 33.58% | CHEMBL28650 |
| Peramivir | AMPN_HUMAN | alanyl aminopeptidase, membrane | -7.44 | -7.65 | -7.07 | 41.58% | CHEMBL28650 |
| Baloxavir | AMPN_HUMAN | alanyl aminopeptidase, membrane | -9.63 | -9.81 | -9.35 | 31.27% | CHEMBL1077583 |
| Zanamivir | AOFA_HUMAN | monoamine oxidase A | -6.68 | -7.28 | -7.49 | 20.26% | CHEMBL3407586 |
| Laninamivir | AOFA_HUMAN | monoamine oxidase A | -7.44 | -6.81 | -7.44 | 21.74% | CHEMBL3127968 |
| Oseltamivir | AOFA_HUMAN | monoamine oxidase A | -7.51 | -7.88 | -7.83 | 25.31% | CHEMBL332223 |
| Peramivir | AOFA_HUMAN | monoamine oxidase A | -8.13 | -7.94 | -7.51 | 21.10% | CHEMBL3415788 |
| Baloxavir | AOFA_HUMAN | monoamine oxidase A | -5.03 | -7.80 | 1.74 | 30.12% | CHEMBL3407582 |
| Zanamivir | AOFB_HUMAN | monoamine oxidase B | -7.76 | -6.67 | -6.83 | 20.86% | CHEMBL3770343 |
| Laninamivir | AOFB_HUMAN | monoamine oxidase B | -7.79 | -6.59 | -6.70 | 22.01% | CHEMBL522271 |
| Oseltamivir | AOFB_HUMAN | monoamine oxidase B | -7.78 | -7.54 | -7.74 | 34.04% | CHEMBL4062286 |
| Peramivir | AOFB_HUMAN | monoamine oxidase B | -8.45 | -7.08 | -7.50 | 29.06% | CHEMBL3604126 |
| Baloxavir | AOFB_HUMAN | monoamine oxidase B | -3.04 | -0.20 | -1.69 | 30.12% | CHEMBL3407582 |
| Zanamivir | BACE1_HUMAN | beta-secretase 1 | -5.79 | -6.45 | -6.73 | 37.25% | CHEMBL2047045 |
| Laninamivir | BACE1_HUMAN | beta-secretase 1 | -6.06 | -6.13 | -6.68 | 38.16% | CHEMBL508303 |
| Oseltamivir | BACE1_HUMAN | beta-secretase 1 | -5.68 | -6.32 | -6.46 | 43.79% | CHEMBL2047043 |
| Peramivir | BACE1_HUMAN | beta-secretase 1 | -6.44 | -6.37 | -7.04 | 50.50% | CHEMBL343757 |
| Baloxavir | BACE1_HUMAN | beta-secretase 1 | -9.17 | -9.48 | -8.92 | 36.39% | CHEMBL3947150 |
| Zanamivir | CAH2_HUMAN | carbonic anhydrase 2 | -6.69 | -6.65 | -6.79 | 32.33% | CHEMBL4063719 |
| Laninamivir | CAH2_HUMAN | carbonic anhydrase 2 | -6.43 | -6.84 | -6.49 | 38.78% | CHEMBL4063719 |
| Oseltamivir | CAH2_HUMAN | carbonic anhydrase 2 | -6.64 | -7.20 | -6.89 | 35.44% | CHEMBL2325975 |
| Peramivir | CAH2_HUMAN | carbonic anhydrase 2 | -7.58 | -6.63 | -6.64 | 37.36% | CHEMBL3400807 |
| Baloxavir | CAH2_HUMAN | carbonic anhydrase 2 | -8.70 | -8.32 | -8.02 | 34.02% | CHEMBL501294 |
| Zanamivir | CASP1_HUMAN | caspase 1 | -6.11 | -6.33 | -5.80 | 46.46% | CHEMBL466747 |
| Laninamivir | CASP1_HUMAN | caspase 1 | -5.82 | -6.00 | -5.81 | 46.38% | CHEMBL466747 |
| Oseltamivir | CASP1_HUMAN | caspase 1 | -5.17 | -6.16 | -5.31 | 45.56% | CHEMBL200819 |
| Peramivir | CASP1_HUMAN | caspase 1 | -5.56 | -5.68 | -5.82 | 46.39% | CHEMBL466565 |
| Baloxavir | CASP1_HUMAN | caspase 1 | -6.55 | -7.58 | -7.09 | 32.29% | CHEMBL437526 |
| Zanamivir | CDK5_HUMAN | cyclin dependent kinase 5 | -5.70 | -6.20 | -5.49 | 26.83% | CHEMBL1980995 |
| Laninamivir | CDK5_HUMAN | cyclin dependent kinase 5 | -5.46 | -5.97 | -4.85 | 29.48% | CHEMBL1980995 |
| Oseltamivir | CDK5_HUMAN | cyclin dependent kinase 5 | -6.57 | -6.61 | -6.18 | 28.00% | CHEMBL1967878 |
| Peramivir | CDK5_HUMAN | cyclin dependent kinase 5 | -6.94 | -8.10 | -7.70 | 26.26% | CHEMBL1994526 |
| Baloxavir | CDK5_HUMAN | cyclin dependent kinase 5 | -6.87 | -6.91 | -5.91 | 33.59% | CHEMBL178737 |
| Zanamivir | CHLE_HUMAN | butyrylcholinesterase | -7.71 | -7.33 | -7.81 | 32.58% | CHEMBL504924 |
| Laninamivir | CHLE_HUMAN | butyrylcholinesterase | -7.61 | -7.31 | -7.96 | 33.16% | CHEMBL504924 |
| Oseltamivir | CHLE_HUMAN | butyrylcholinesterase | -7.52 | -7.32 | -7.80 | 46.46% | CHEMBL504924 |
| Peramivir | CHLE_HUMAN | butyrylcholinesterase | -7.66 | -7.66 | -7.78 | 46.67% | CHEMBL1512936 |
| Baloxavir | CHLE_HUMAN | butyrylcholinesterase | -11.29 | -11.49 | -10.78 | 31.84% | CHEMBL2019035 |
| Zanamivir | CNR1_HUMAN | cannabinoid receptor 1 | -7.15 | -6.82 | -6.92 | 32.40% | CHEMBL3597330 |
| Laninamivir | CNR1_HUMAN | cannabinoid receptor 1 | -5.90 | -6.91 | -7.05 | 32.14% | CHEMBL1800731 |
| Oseltamivir | CNR1_HUMAN | cannabinoid receptor 1 | -5.75 | -7.54 | -7.99 | 47.24% | CHEMBL3597330 |
| Peramivir | CNR1_HUMAN | cannabinoid receptor 1 | -7.00 | -7.00 | -7.58 | 50.00% | CHEMBL483143 |
| Baloxavir | CNR1_HUMAN | cannabinoid receptor 1 | -5.81 | -8.27 | -6.57 | 37.13% | CHEMBL66956 |
| Zanamivir | CNR2_HUMAN | cannabinoid receptor 2 | -6.22 | -6.93 | N/A | 32.22% | CHEMBL3597331 |
| Laninamivir | CNR2_HUMAN | cannabinoid receptor 2 | -6.07 | -7.05 | N/A | 32.14% | CHEMBL1800731 |
| Oseltamivir | CNR2_HUMAN | cannabinoid receptor 2 | -7.51 | -7.48 | N/A | 46.88% | CHEMBL3597331 |
| Peramivir | CNR2_HUMAN | cannabinoid receptor 2 | -7.73 | -7.09 | N/A | 43.40% | CHEMBL1765285 |
| Baloxavir | CNR2_HUMAN | cannabinoid receptor 2 | -5.36 | -6.68 | N/A | 37.13% | CHEMBL66956 |
| Zanamivir | COLI_HUMAN | proopiomelanocortin | -6.54 | -6.15 | -6.35 | N/A | N/A |
| Laninamivir | COLI_HUMAN | proopiomelanocortin | -6.76 | -6.16 | -5.85 | N/A | N/A |
| Oseltamivir | COLI_HUMAN | proopiomelanocortin | -6.71 | -6.53 | -5.80 | N/A | N/A |
| Peramivir | COLI_HUMAN | proopiomelanocortin | -7.72 | -7.82 | -5.83 | N/A | N/A |
| Baloxavir | COLI_HUMAN | proopiomelanocortin | -8.10 | -7.64 | -8.41 | N/A | N/A |
| Zanamivir | COMT_HUMAN | catechol-O-methyltransferase | -5.17 | -5.24 | -5.68 | 23.73% | CHEMBL3819488 |
| Laninamivir | COMT_HUMAN | catechol-O-methyltransferase | -5.02 | -4.53 | -5.05 | 26.85% | CHEMBL3819488 |
| Oseltamivir | COMT_HUMAN | catechol-O-methyltransferase | -5.08 | -4.86 | -5.25 | 21.15% | CHEMBL3819488 |
| Peramivir | COMT_HUMAN | catechol-O-methyltransferase | -4.97 | -5.00 | -5.38 | 23.87% | CHEMBL3819488 |
| Baloxavir | COMT_HUMAN | catechol-O-methyltransferase | -6.83 | -6.35 | -5.49 | 27.85% | CHEMBL3425721 |
| Zanamivir | CRP_HUMAN | C-reactive protein | -5.79 | -5.57 | N/A | N/A | N/A |
| Laninamivir | CRP_HUMAN | C-reactive protein | -5.57 | -5.78 | N/A | N/A | N/A |
| Oseltamivir | CRP_HUMAN | C-reactive protein | -4.84 | -5.15 | N/A | N/A | N/A |
| Peramivir | CRP_HUMAN | C-reactive protein | -5.34 | -5.31 | N/A | N/A | N/A |
| Baloxavir | CRP_HUMAN | C-reactive protein | -6.44 | -6.62 | N/A | N/A | N/A |
| Zanamivir | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -6.12 | N/A | N/A | 23.37% | CHEMBL3906175 |
| Laninamivir | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -5.88 | N/A | N/A | 23.44% | CHEMBL3701188 |
| Oseltamivir | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -7.08 | N/A | N/A | 24.81% | CHEMBL3701188 |
| Peramivir | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | -7.35 | N/A | N/A | 19.80% | CHEMBL387136 |
| Baloxavir | CXCR1_HUMAN | C-X-C motif chemokine receptor 1 | 8.98 | N/A | N/A | 30.64% | CHEMBL3906175 |
| Zanamivir | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -6.71 | -6.52 | -6.42 | 35.91% | CHEMBL1221944 |
| Laninamivir | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -6.83 | -6.40 | -6.57 | 38.26% | CHEMBL1221944 |
| Oseltamivir | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -6.59 | -6.15 | -6.30 | 41.12% | CHEMBL1221944 |
| Peramivir | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -7.89 | -6.57 | -7.26 | 39.37% | CHEMBL366033 |
| Baloxavir | CXCR4_HUMAN | C-X-C motif chemokine receptor 4 | -9.64 | -8.59 | -8.27 | 33.73% | CHEMBL3908632 |
| Zanamivir | DRD2_HUMAN | dopamine receptor D2 | -5.96 | N/A | N/A | 33.62% | CHEMBL539521 |
| Laninamivir | DRD2_HUMAN | dopamine receptor D2 | -5.77 | N/A | N/A | 35.23% | CHEMBL3265319 |
| Oseltamivir | DRD2_HUMAN | dopamine receptor D2 | -6.28 | N/A | N/A | 37.75% | CHEMBL282927 |
| Peramivir | DRD2_HUMAN | dopamine receptor D2 | -6.15 | N/A | N/A | 35.14% | CHEMBL2436139 |
| Baloxavir | DRD2_HUMAN | dopamine receptor D2 | -8.69 | N/A | N/A | 32.34% | CHEMBL2159468 |
| Zanamivir | DRD3_HUMAN | dopamine receptor D3 | -6.68 | N/A | N/A | 33.46% | CHEMBL3577342 |
| Laninamivir | DRD3_HUMAN | dopamine receptor D3 | -6.15 | N/A | N/A | 32.83% | CHEMBL3577342 |
| Oseltamivir | DRD3_HUMAN | dopamine receptor D3 | -6.61 | N/A | N/A | 38.05% | CHEMBL1123 |
| Peramivir | DRD3_HUMAN | dopamine receptor D3 | -7.30 | N/A | N/A | 34.26% | CHEMBL49 |
| Baloxavir | DRD3_HUMAN | dopamine receptor D3 | -8.71 | N/A | N/A | 31.74% | CHEMBL113524 |
| Zanamivir | DRD4_HUMAN | dopamine receptor D4 | -7.00 | -7.19 | N/A | 33.46% | CHEMBL3577342 |
| Laninamivir | DRD4_HUMAN | dopamine receptor D4 | -6.95 | -7.13 | N/A | 32.83% | CHEMBL3577342 |
| Oseltamivir | DRD4_HUMAN | dopamine receptor D4 | -7.11 | -7.12 | N/A | 37.75% | CHEMBL282927 |
| Peramivir | DRD4_HUMAN | dopamine receptor D4 | -7.75 | -7.92 | N/A | 34.86% | CHEMBL1779058 |
| Baloxavir | DRD4_HUMAN | dopamine receptor D4 | -7.74 | -6.69 | N/A | 30.77% | CHEMBL1627311 |
| Zanamivir | EDN1_HUMAN | endothelin 1 | -6.78 | N/A | N/A | N/A | N/A |
| Laninamivir | EDN1_HUMAN | endothelin 1 | -6.24 | N/A | N/A | N/A | N/A |
| Oseltamivir | EDN1_HUMAN | endothelin 1 | -6.31 | N/A | N/A | N/A | N/A |
| Peramivir | EDN1_HUMAN | endothelin 1 | -6.78 | N/A | N/A | N/A | N/A |
| Baloxavir | EDN1_HUMAN | endothelin 1 | -7.76 | N/A | N/A | N/A | N/A |
| Zanamivir | ESR1_HUMAN | estrogen receptor 1 | -6.36 | -6.21 | -6.49 | 29.44% | CHEMBL240828 |
| Laninamivir | ESR1_HUMAN | estrogen receptor 1 | -6.07 | -6.35 | -6.41 | 28.79% | CHEMBL3597505 |
| Oseltamivir | ESR1_HUMAN | estrogen receptor 1 | -6.75 | -6.99 | -6.99 | 37.80% | CHEMBL241041 |
| Peramivir | ESR1_HUMAN | estrogen receptor 1 | -6.72 | -6.64 | -6.74 | 43.82% | CHEMBL3597502 |
| Baloxavir | ESR1_HUMAN | estrogen receptor 1 | -5.32 | -6.40 | -6.30 | 32.65% | CHEMBL240438 |
| Zanamivir | FABP5_HUMAN | fatty acid binding protein 5 | -7.08 | -6.11 | -5.87 | 21.79% | CHEMBL3920801 |
| Laninamivir | FABP5_HUMAN | fatty acid binding protein 5 | -7.02 | -5.32 | -5.65 | 22.83% | CHEMBL3943278 |
| Oseltamivir | FABP5_HUMAN | fatty acid binding protein 5 | -6.84 | -5.42 | -4.92 | 25.89% | CHEMBL8659 |
| Peramivir | FABP5_HUMAN | fatty acid binding protein 5 | -7.52 | -5.42 | -5.38 | 27.14% | CHEMBL82293 |
| Baloxavir | FABP5_HUMAN | fatty acid binding protein 5 | -8.93 | -6.74 | -7.45 | 25.00% | CHEMBL394440 |
| Zanamivir | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -6.36 | N/A | N/A | 26.83% | CHEMBL388978 |
| Laninamivir | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -6.36 | N/A | N/A | 29.48% | CHEMBL388978 |
| Oseltamivir | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -6.63 | N/A | N/A | 31.62% | CHEMBL407135 |
| Peramivir | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -7.19 | N/A | N/A | 47.87% | CHEMBL407135 |
| Baloxavir | FYN_HUMAN | FYN proto-oncogene, Src family tyrosine kinase | -8.03 | N/A | N/A | 29.49% | CHEMBL301143 |
| Zanamivir | GLRA3_HUMAN | glycine receptor alpha 3 | -7.05 | -7.28 | -7.23 | 13.27% | CHEMBL4070615 |
| Zanamivir | GLRA3_HUMAN | glycine receptor alpha 3 | -7.09 | N/A | N/A | 13.27% | CHEMBL4070615 |
| Laninamivir | GLRA3_HUMAN | glycine receptor alpha 3 | -6.81 | -7.17 | -6.90 | 12.38% | CHEMBL4070615 |
| Laninamivir | GLRA3_HUMAN | glycine receptor alpha 3 | -7.07 | N/A | N/A | 12.38% | CHEMBL4070615 |
| Oseltamivir | GLRA3_HUMAN | glycine receptor alpha 3 | -7.16 | -7.59 | -7.32 | 15.83% | CHEMBL4070615 |
| Oseltamivir | GLRA3_HUMAN | glycine receptor alpha 3 | -7.17 | N/A | N/A | 15.83% | CHEMBL4070615 |
| Peramivir | GLRA3_HUMAN | glycine receptor alpha 3 | -8.24 | -8.46 | -8.33 | 14.54% | CHEMBL4070615 |
| Peramivir | GLRA3_HUMAN | glycine receptor alpha 3 | -7.32 | N/A | N/A | 14.54% | CHEMBL4070615 |
| Baloxavir | GLRA3_HUMAN | glycine receptor alpha 3 | -8.80 | -8.58 | -6.95 | 24.27% | CHEMBL4070615 |
| Baloxavir | GLRA3_HUMAN | glycine receptor alpha 3 | -5.91 | N/A | N/A | 24.27% | CHEMBL4070615 |
| Zanamivir | GRM5_HUMAN | glutamate metabotropic receptor 5 | -7.87 | -3.60 | -2.19 | 31.37% | CHEMBL3086720 |
| Laninamivir | GRM5_HUMAN | glutamate metabotropic receptor 5 | -6.41 | -3.60 | -2.13 | 30.70% | CHEMBL3086720 |
| Oseltamivir | GRM5_HUMAN | glutamate metabotropic receptor 5 | -7.04 | -7.72 | -7.56 | 27.69% | CHEMBL3926962 |
| Peramivir | GRM5_HUMAN | glutamate metabotropic receptor 5 | -7.11 | -5.46 | -4.84 | 40.54% | CHEMBL1783985 |
| Baloxavir | GRM5_HUMAN | glutamate metabotropic receptor 5 | 5.55 | 20.81 | 14.16 | 32.68% | CHEMBL3605290 |
| Zanamivir | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.57 | -5.75 | -5.27 | 27.12% | CHEMBL3698260 |
| Laninamivir | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.64 | -5.54 | -5.60 | 31.51% | CHEMBL3698260 |
| Oseltamivir | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.01 | -5.12 | -5.77 | 30.89% | CHEMBL3698260 |
| Peramivir | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -6.88 | -5.67 | -5.91 | 26.90% | CHEMBL3650199 |
| Baloxavir | HPGDS_HUMAN | hematopoietic prostaglandin D synthase | -7.87 | -7.83 | -6.92 | 30.42% | CHEMBL3650209 |
| Zanamivir | HRH1_HUMAN | histamine receptor H1 | -5.89 | N/A | N/A | 27.72% | CHEMBL1278112 |
| Laninamivir | HRH1_HUMAN | histamine receptor H1 | -5.30 | N/A | N/A | 30.17% | CHEMBL2178580 |
| Oseltamivir | HRH1_HUMAN | histamine receptor H1 | -6.86 | N/A | N/A | 32.53% | CHEMBL1278020 |
| Peramivir | HRH1_HUMAN | histamine receptor H1 | -4.98 | N/A | N/A | 35.59% | CHEMBL1276947 |
| Baloxavir | HRH1_HUMAN | histamine receptor H1 | 7.46 | N/A | N/A | 34.10% | CHEMBL94726 |
| Zanamivir | HYES_HUMAN | epoxide hydrolase 2 | -7.93 | -6.61 | -6.34 | 34.85% | CHEMBL375113 |
| Laninamivir | HYES_HUMAN | epoxide hydrolase 2 | -7.91 | -6.87 | -6.60 | 37.93% | CHEMBL375113 |
| Oseltamivir | HYES_HUMAN | epoxide hydrolase 2 | -6.99 | -7.00 | -7.08 | 47.90% | CHEMBL561665 |
| Peramivir | HYES_HUMAN | epoxide hydrolase 2 | -7.64 | -7.82 | -6.67 | 62.03% | CHEMBL426340 |
| Baloxavir | HYES_HUMAN | epoxide hydrolase 2 | -9.97 | -8.98 | -10.51 | 33.33% | CHEMBL3104435 |
| Zanamivir | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -6.51 | N/A | N/A | 32.61% | CHEMBL1672879 |
| Laninamivir | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -5.91 | N/A | N/A | 35.32% | CHEMBL1672879 |
| Oseltamivir | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -6.89 | N/A | N/A | 43.26% | CHEMBL1672879 |
| Peramivir | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -6.41 | N/A | N/A | 27.22% | CHEMBL1672879 |
| Baloxavir | IKKB_HUMAN | inhibitor of nuclear factor kappa B kinase subunit beta | -6.61 | N/A | N/A | 33.41% | CHEMBL3926437 |
| Zanamivir | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -6.96 | -6.76 | N/A | 45.50% | CHEMBL2075043 |
| Laninamivir | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -6.39 | -6.66 | N/A | 46.79% | CHEMBL2075043 |
| Oseltamivir | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -6.71 | -6.38 | N/A | 55.76% | CHEMBL2075043 |
| Peramivir | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -6.60 | -6.80 | N/A | 50.00% | CHEMBL2075030 |
| Baloxavir | MDR1_HUMAN | ATP binding cassette subfamily B member 1 | -8.52 | -9.04 | N/A | 34.96% | CHEMBL1256399 |
| Zanamivir | MIF_HUMAN | macrophage migration inhibitory factor | -4.96 | -5.65 | -4.84 | 27.76% | CHEMBL2375651 |
| Laninamivir | MIF_HUMAN | macrophage migration inhibitory factor | -4.92 | -5.24 | -4.74 | 27.42% | CHEMBL2375651 |
| Oseltamivir | MIF_HUMAN | macrophage migration inhibitory factor | -5.81 | -5.99 | -5.73 | 31.69% | CHEMBL2375653 |
| Peramivir | MIF_HUMAN | macrophage migration inhibitory factor | -4.90 | -6.25 | -5.12 | 23.78% | CHEMBL554271 |
| Baloxavir | MIF_HUMAN | macrophage migration inhibitory factor | -4.96 | -7.45 | -5.51 | 24.67% | CHEMBL3797437 |
| Zanamivir | MK01_HUMAN | mitogen-activated protein kinase 1 | -5.52 | -6.74 | -6.11 | 26.83% | CHEMBL388978 |
| Laninamivir | MK01_HUMAN | mitogen-activated protein kinase 1 | -5.38 | -6.29 | -6.20 | 31.23% | CHEMBL4076347 |
| Oseltamivir | MK01_HUMAN | mitogen-activated protein kinase 1 | -6.20 | -6.44 | -6.50 | 30.77% | CHEMBL3752989 |
| Peramivir | MK01_HUMAN | mitogen-activated protein kinase 1 | -6.73 | -7.02 | -6.32 | 28.12% | CHEMBL3752989 |
| Baloxavir | MK01_HUMAN | mitogen-activated protein kinase 1 | -6.93 | -6.66 | -7.29 | 37.98% | CHEMBL4115102 |
| Zanamivir | MK03_HUMAN | mitogen-activated protein kinase 3 | -5.63 | -6.62 | -6.04 | 24.83% | CHEMBL444109 |
| Laninamivir | MK03_HUMAN | mitogen-activated protein kinase 3 | -6.02 | -6.58 | -6.65 | 25.85% | CHEMBL444109 |
| Oseltamivir | MK03_HUMAN | mitogen-activated protein kinase 3 | -6.48 | -7.02 | -6.04 | 27.33% | CHEMBL3113587 |
| Peramivir | MK03_HUMAN | mitogen-activated protein kinase 3 | -6.55 | -7.09 | -6.69 | 28.91% | CHEMBL3113587 |
| Baloxavir | MK03_HUMAN | mitogen-activated protein kinase 3 | -6.56 | -6.96 | -7.51 | 26.17% | CHEMBL3798015 |
| Zanamivir | MTOR_HUMAN | mechanistic target of rapamycin kinase | -6.47 | -6.98 | -6.67 | 41.78% | CHEMBL269732 |
| Laninamivir | MTOR_HUMAN | mechanistic target of rapamycin kinase | -6.30 | -6.90 | -6.28 | 42.53% | CHEMBL269732 |
| Oseltamivir | MTOR_HUMAN | mechanistic target of rapamycin kinase | -6.84 | -7.36 | -6.89 | 50.00% | CHEMBL269732 |
| Peramivir | MTOR_HUMAN | mechanistic target of rapamycin kinase | -7.21 | -7.86 | -7.14 | 35.92% | CHEMBL3972399 |
| Baloxavir | MTOR_HUMAN | mechanistic target of rapamycin kinase | -10.23 | -10.76 | -10.35 | 33.68% | CHEMBL3983827 |
| Zanamivir | NEP_HUMAN | membrane metalloendopeptidase | -7.38 | -7.36 | -7.01 | 27.84% | CHEMBL434492 |
| Laninamivir | NEP_HUMAN | membrane metalloendopeptidase | -6.99 | -6.51 | -6.20 | 29.35% | CHEMBL434492 |
| Oseltamivir | NEP_HUMAN | membrane metalloendopeptidase | -6.66 | -6.51 | -7.47 | 36.72% | CHEMBL434492 |
| Peramivir | NEP_HUMAN | membrane metalloendopeptidase | -7.19 | -7.21 | -7.42 | 56.58% | CHEMBL213861 |
| Baloxavir | NEP_HUMAN | membrane metalloendopeptidase | -9.14 | -9.42 | -8.09 | 30.09% | CHEMBL3145341 |
| Zanamivir | NK1R_HUMAN | tachykinin receptor 1 | -6.65 | -5.87 | -5.92 | 40.81% | CHEMBL1090438 |
| Laninamivir | NK1R_HUMAN | tachykinin receptor 1 | -7.10 | -6.30 | -6.10 | 40.34% | CHEMBL1090438 |
| Oseltamivir | NK1R_HUMAN | tachykinin receptor 1 | -7.16 | -7.04 | -6.44 | 43.28% | CHEMBL1090437 |
| Peramivir | NK1R_HUMAN | tachykinin receptor 1 | -7.44 | -7.38 | -7.46 | 40.00% | CHEMBL3922114 |
| Baloxavir | NK1R_HUMAN | tachykinin receptor 1 | -9.71 | -8.36 | -9.44 | 31.84% | CHEMBL250974 |
| Zanamivir | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -7.19 | -7.13 | -6.62 | 11.54% | CHEMBL2333945 |
| Laninamivir | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -7.41 | -6.97 | -6.07 | 11.38% | CHEMBL2333945 |
| Oseltamivir | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -7.49 | -7.19 | -6.80 | 11.66% | CHEMBL284237 |
| Peramivir | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -7.64 | -7.78 | -6.41 | 9.23% | CHEMBL284237 |
| Baloxavir | NMDE1_HUMAN | glutamate ionotropic receptor NMDA type subunit 2A | -8.25 | -8.42 | -8.64 | 18.77% | CHEMBL284237 |
| Zanamivir | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.75 | -7.67 | -5.86 | 19.09% | CHEMBL247114 |
| Laninamivir | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.61 | -7.32 | -5.85 | 21.05% | CHEMBL218547 |
| Oseltamivir | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.70 | -7.87 | -7.45 | 21.02% | CHEMBL218547 |
| Peramivir | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -7.34 | -8.48 | -6.31 | 26.15% | CHEMBL218068 |
| Baloxavir | NMDE2_HUMAN | glutamate ionotropic receptor NMDA type subunit 2B | -6.73 | -5.24 | -6.82 | 29.64% | CHEMBL1779013 |
| Zanamivir | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -7.35 | -7.33 | -6.62 | 21.37% | CHEMBL354003 |
| Laninamivir | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -6.89 | -7.09 | -6.07 | 23.97% | CHEMBL354003 |
| Oseltamivir | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -7.42 | -7.09 | -6.80 | 22.94% | CHEMBL354003 |
| Peramivir | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -7.41 | -7.42 | -6.41 | 21.28% | CHEMBL354003 |
| Baloxavir | NMDZ1_HUMAN | glutamate ionotropic receptor NMDA type subunit 1 | -8.41 | -8.41 | -8.64 | 29.03% | CHEMBL435844 |
| Zanamivir | NOS1_HUMAN | nitric oxide synthase 1 | -7.11 | -6.91 | -7.35 | 30.10% | CHEMBL317521 |
| Laninamivir | NOS1_HUMAN | nitric oxide synthase 1 | -7.24 | -6.64 | -7.27 | 30.24% | CHEMBL1270460 |
| Oseltamivir | NOS1_HUMAN | nitric oxide synthase 1 | -7.25 | -7.40 | -7.55 | 33.99% | CHEMBL317521 |
| Peramivir | NOS1_HUMAN | nitric oxide synthase 1 | -7.27 | -7.23 | -7.76 | 50.00% | CHEMBL332148 |
| Baloxavir | NOS1_HUMAN | nitric oxide synthase 1 | -8.70 | -9.14 | -8.60 | 29.39% | CHEMBL491923 |
| Zanamivir | NOS2_HUMAN | nitric oxide synthase 2 | -7.96 | -7.81 | -7.26 | 22.46% | CHEMBL1037 |
| Laninamivir | NOS2_HUMAN | nitric oxide synthase 2 | -7.00 | -7.70 | -7.07 | 27.37% | CHEMBL1037 |
| Oseltamivir | NOS2_HUMAN | nitric oxide synthase 2 | -7.37 | -7.11 | -7.14 | 30.16% | CHEMBL195352 |
| Peramivir | NOS2_HUMAN | nitric oxide synthase 2 | -7.14 | -7.52 | -8.14 | 51.35% | CHEMBL7889 |
| Baloxavir | NOS2_HUMAN | nitric oxide synthase 2 | -6.65 | -8.85 | 2.88 | 30.75% | CHEMBL1911986 |
| Zanamivir | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -5.96 | -6.06 | -6.13 | 26.83% | CHEMBL1980995 |
| Laninamivir | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -6.49 | -6.27 | -6.06 | 29.48% | CHEMBL1980995 |
| Oseltamivir | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -6.53 | -6.40 | -6.80 | 25.94% | CHEMBL416056 |
| Peramivir | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -6.01 | -7.32 | -6.93 | 24.12% | CHEMBL3403444 |
| Baloxavir | NTRK1_HUMAN | neurotrophic receptor tyrosine kinase 1 | -8.14 | -8.29 | -7.15 | 34.04% | CHEMBL3911052 |
| Zanamivir | OPRD_HUMAN | opioid receptor delta 1 | -5.94 | -5.83 | -6.21 | 39.48% | CHEMBL1743604 |
| Laninamivir | OPRD_HUMAN | opioid receptor delta 1 | -6.64 | -5.48 | -6.14 | 37.68% | CHEMBL1743604 |
| Oseltamivir | OPRD_HUMAN | opioid receptor delta 1 | -6.35 | -5.85 | -6.10 | 39.57% | CHEMBL1743604 |
| Peramivir | OPRD_HUMAN | opioid receptor delta 1 | -6.69 | -5.88 | -6.54 | 40.15% | CHEMBL409969 |
| Baloxavir | OPRD_HUMAN | opioid receptor delta 1 | -9.30 | -8.66 | -9.20 | 34.58% | CHEMBL494854 |
| Zanamivir | OPRK_HUMAN | opioid receptor kappa 1 | -7.09 | -6.28 | -6.40 | 39.48% | CHEMBL1743604 |
| Laninamivir | OPRK_HUMAN | opioid receptor kappa 1 | -7.09 | -6.86 | -6.58 | 37.68% | CHEMBL1743604 |
| Oseltamivir | OPRK_HUMAN | opioid receptor kappa 1 | -7.38 | -7.52 | -6.34 | 44.62% | CHEMBL3219944 |
| Peramivir | OPRK_HUMAN | opioid receptor kappa 1 | -7.36 | -7.03 | -6.70 | 45.76% | CHEMBL4112830 |
| Baloxavir | OPRK_HUMAN | opioid receptor kappa 1 | -11.81 | -9.18 | -8.66 | 34.58% | CHEMBL494854 |
| Zanamivir | OPRM_MOUSE | Mu-type opioid receptor | -5.93 | -6.61 | N/A | 33.48% | CHEMBL405663 |
| Laninamivir | OPRM_MOUSE | Mu-type opioid receptor | -5.63 | -6.64 | N/A | 33.90% | CHEMBL405663 |
| Oseltamivir | OPRM_MOUSE | Mu-type opioid receptor | -6.31 | -6.61 | N/A | 46.40% | CHEMBL2057689 |
| Peramivir | OPRM_MOUSE | Mu-type opioid receptor | -5.99 | -6.84 | N/A | 34.78% | CHEMBL440765 |
| Baloxavir | OPRM_MOUSE | Mu-type opioid receptor | -9.23 | -10.16 | N/A | 37.64% | CHEMBL2419121 |
| Zanamivir | OPRX_HUMAN | opioid related nociceptin receptor 1 | -6.12 | -5.55 | -5.78 | 31.75% | CHEMBL265801 |
| Laninamivir | OPRX_HUMAN | opioid related nociceptin receptor 1 | -6.68 | -6.06 | -6.24 | 31.36% | CHEMBL507269 |
| Oseltamivir | OPRX_HUMAN | opioid related nociceptin receptor 1 | -6.22 | -5.95 | -6.41 | 32.93% | CHEMBL1783822 |
| Peramivir | OPRX_HUMAN | opioid related nociceptin receptor 1 | -6.72 | -6.27 | -6.18 | 45.04% | CHEMBL396460 |
| Baloxavir | OPRX_HUMAN | opioid related nociceptin receptor 1 | -8.69 | -8.21 | -9.46 | 31.73% | CHEMBL3236475 |
| Zanamivir | P2RX3_HUMAN | purinergic receptor P2X 3 | -5.91 | -5.26 | -5.96 | 30.55% | CHEMBL3679845 |
| Laninamivir | P2RX3_HUMAN | purinergic receptor P2X 3 | -5.14 | -4.96 | -6.22 | 31.76% | CHEMBL3679845 |
| Oseltamivir | P2RX3_HUMAN | purinergic receptor P2X 3 | -5.17 | -4.60 | -5.04 | 35.16% | CHEMBL3669852 |
| Peramivir | P2RX3_HUMAN | purinergic receptor P2X 3 | -5.83 | -5.07 | -5.82 | 26.14% | CHEMBL3895492 |
| Baloxavir | P2RX3_HUMAN | purinergic receptor P2X 3 | -7.09 | -6.33 | -6.60 | 35.34% | CHEMBL3679943 |
| Zanamivir | P2Y12_HUMAN | purinergic receptor P2Y12 | -5.75 | -5.68 | -7.13 | 28.85% | CHEMBL590748 |
| Laninamivir | P2Y12_HUMAN | purinergic receptor P2Y12 | -5.90 | -5.33 | -7.41 | 31.52% | CHEMBL590069 |
| Oseltamivir | P2Y12_HUMAN | purinergic receptor P2Y12 | -6.92 | -5.69 | -6.72 | 30.11% | CHEMBL88444 |
| Peramivir | P2Y12_HUMAN | purinergic receptor P2Y12 | -6.49 | -4.77 | -7.05 | 31.85% | CHEMBL599606 |
| Baloxavir | P2Y12_HUMAN | purinergic receptor P2Y12 | -7.61 | 4.81 | -3.92 | 32.94% | CHEMBL3652613 |
| Zanamivir | PAR1_HUMAN | coagulation factor II thrombin receptor | -5.31 | N/A | N/A | 31.73% | CHEMBL3925032 |
| Laninamivir | PAR1_HUMAN | coagulation factor II thrombin receptor | -5.43 | N/A | N/A | 31.66% | CHEMBL3925032 |
| Oseltamivir | PAR1_HUMAN | coagulation factor II thrombin receptor | -7.85 | N/A | N/A | 38.46% | CHEMBL3892331 |
| Peramivir | PAR1_HUMAN | coagulation factor II thrombin receptor | -5.38 | N/A | N/A | 57.14% | CHEMBL80672 |
| Baloxavir | PAR1_HUMAN | coagulation factor II thrombin receptor | -7.26 | N/A | N/A | 34.39% | CHEMBL3662513 |
| Zanamivir | PDE4B_HUMAN | phosphodiesterase 4B | -6.99 | -7.10 | -7.48 | 27.69% | CHEMBL451500 |
| Laninamivir | PDE4B_HUMAN | phosphodiesterase 4B | -7.08 | -7.55 | -7.59 | 27.27% | CHEMBL3315267 |
| Oseltamivir | PDE4B_HUMAN | phosphodiesterase 4B | -7.38 | -6.62 | -6.92 | 30.56% | CHEMBL451500 |
| Peramivir | PDE4B_HUMAN | phosphodiesterase 4B | -7.53 | -7.84 | -7.43 | 29.32% | CHEMBL144499 |
| Baloxavir | PDE4B_HUMAN | phosphodiesterase 4B | -8.95 | -9.17 | -9.97 | 37.61% | CHEMBL3288003 |
| Zanamivir | PDE5A_HUMAN | phosphodiesterase 5A | -7.69 | -7.38 | -7.15 | 27.63% | CHEMBL190364 |
| Laninamivir | PDE5A_HUMAN | phosphodiesterase 5A | -6.76 | -7.57 | -7.44 | 26.67% | CHEMBL190364 |
| Oseltamivir | PDE5A_HUMAN | phosphodiesterase 5A | -6.55 | -7.19 | -6.35 | 28.19% | CHEMBL190364 |
| Peramivir | PDE5A_HUMAN | phosphodiesterase 5A | -7.08 | -7.95 | -6.52 | 27.66% | CHEMBL190423 |
| Baloxavir | PDE5A_HUMAN | phosphodiesterase 5A | -7.90 | -8.14 | -8.17 | 39.94% | CHEMBL342404 |
| Zanamivir | PERM_HUMAN | myeloperoxidase | -6.57 | -7.08 | -6.70 | 19.20% | CHEMBL3740464 |
| Laninamivir | PERM_HUMAN | myeloperoxidase | -7.66 | -7.64 | -7.10 | 18.70% | CHEMBL3740464 |
| Oseltamivir | PERM_HUMAN | myeloperoxidase | -6.67 | -6.80 | -6.70 | 19.88% | CHEMBL490 |
| Peramivir | PERM_HUMAN | myeloperoxidase | -7.01 | -7.71 | -7.60 | 22.79% | CHEMBL1409565 |
| Baloxavir | PERM_HUMAN | myeloperoxidase | -9.42 | -9.30 | -9.44 | 32.50% | CHEMBL3739930 |
| Zanamivir | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -5.04 | -5.28 | -4.85 | 35.75% | CHEMBL502799 |
| Laninamivir | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -4.39 | -5.29 | -4.84 | 36.14% | CHEMBL502799 |
| Oseltamivir | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -6.31 | -7.01 | -7.02 | 45.52% | CHEMBL500387 |
| Peramivir | PGH1_SHEEP | Prostaglandin G/H synthase 1 | -5.41 | -6.64 | -6.81 | 27.78% | CHEMBL3809863 |
| Baloxavir | PGH1_SHEEP | Prostaglandin G/H synthase 1 | 4.91 | -1.12 | 0.57 | 28.49% | CHEMBL2018668 |
| Zanamivir | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -1.31 | -2.97 | -6.17 | 31.87% | CHEMBL463763 |
| Laninamivir | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -1.81 | -3.14 | -6.22 | 33.01% | CHEMBL463571 |
| Oseltamivir | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -5.23 | -5.89 | -7.70 | 42.86% | CHEMBL463763 |
| Peramivir | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | -4.34 | -5.20 | -6.85 | 28.00% | CHEMBL3809120 |
| Baloxavir | PGH2_HUMAN | prostaglandin-endoperoxide synthase 2 | 12.23 | 7.54 | -7.88 | 31.20% | CHEMBL365603 |
| Zanamivir | PPAP_HUMAN | acid phosphatase 3 | -6.89 | N/A | N/A | 9.59% | CHEMBL507996 |
| Laninamivir | PPAP_HUMAN | acid phosphatase 3 | -7.39 | N/A | N/A | 9.05% | CHEMBL507996 |
| Oseltamivir | PPAP_HUMAN | acid phosphatase 3 | -6.34 | N/A | N/A | 10.47% | CHEMBL507996 |
| Peramivir | PPAP_HUMAN | acid phosphatase 3 | -7.17 | N/A | N/A | 8.80% | CHEMBL501717 |
| Baloxavir | PPAP_HUMAN | acid phosphatase 3 | -8.37 | N/A | N/A | 15.58% | CHEMBL507996 |
| Zanamivir | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -6.50 | -6.43 | -6.76 | 29.59% | CHEMBL1836976 |
| Laninamivir | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -5.95 | -6.47 | -6.53 | 30.14% | CHEMBL1836927 |
| Oseltamivir | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -6.69 | -6.55 | -6.48 | 45.69% | CHEMBL1836976 |
| Peramivir | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -6.60 | -6.59 | -6.60 | 37.23% | CHEMBL1836976 |
| Baloxavir | PPARG_HUMAN | peroxisome proliferator activated receptor gamma | -8.20 | -6.16 | -7.41 | 35.08% | CHEMBL238357 |
| Zanamivir | PRGR_HUMAN | progesterone receptor | -6.49 | -6.94 | -6.78 | 29.44% | CHEMBL454121 |
| Laninamivir | PRGR_HUMAN | progesterone receptor | -6.39 | -6.75 | -7.02 | 31.50% | CHEMBL454121 |
| Oseltamivir | PRGR_HUMAN | progesterone receptor | -7.33 | -7.30 | -7.23 | 43.70% | CHEMBL3695612 |
| Peramivir | PRGR_HUMAN | progesterone receptor | -6.69 | -6.67 | -7.38 | 30.53% | CHEMBL503848 |
| Baloxavir | PRGR_HUMAN | progesterone receptor | 1.28 | 1.47 | -5.08 | 34.89% | CHEMBL3315068 |
| Zanamivir | PTGES_HUMAN | prostaglandin E synthase | -6.54 | N/A | N/A | 25.35% | CHEMBL3928608 |
| Laninamivir | PTGES_HUMAN | prostaglandin E synthase | -7.46 | N/A | N/A | 26.13% | CHEMBL3694528 |
| Oseltamivir | PTGES_HUMAN | prostaglandin E synthase | -6.03 | N/A | N/A | 35.04% | CHEMBL3289097 |
| Peramivir | PTGES_HUMAN | prostaglandin E synthase | -7.61 | N/A | N/A | 38.68% | CHEMBL3919693 |
| Baloxavir | PTGES_HUMAN | prostaglandin E synthase | -7.38 | N/A | N/A | 30.20% | CHEMBL3971684 |
| Zanamivir | SC6A4_HUMAN | solute carrier family 6 member 4 | -7.97 | -7.91 | -7.68 | 33.18% | CHEMBL316428 |
| Laninamivir | SC6A4_HUMAN | solute carrier family 6 member 4 | -7.25 | -7.35 | -7.93 | 32.77% | CHEMBL421546 |
| Oseltamivir | SC6A4_HUMAN | solute carrier family 6 member 4 | -7.15 | -7.16 | -7.61 | 42.29% | CHEMBL421546 |
| Peramivir | SC6A4_HUMAN | solute carrier family 6 member 4 | -7.70 | -7.64 | -8.43 | 35.04% | CHEMBL561332 |
| Baloxavir | SC6A4_HUMAN | solute carrier family 6 member 4 | -9.56 | -8.81 | -6.03 | 35.06% | CHEMBL400831 |
| Zanamivir | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -5.73 | N/A | N/A | 32.51% | CHEMBL507974 |
| Laninamivir | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -5.56 | N/A | N/A | 33.65% | CHEMBL507974 |
| Oseltamivir | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -5.71 | N/A | N/A | 30.52% | CHEMBL4077213 |
| Peramivir | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -5.82 | N/A | N/A | 50.47% | CHEMBL4077213 |
| Baloxavir | SCN9A_HUMAN | sodium voltage-gated channel alpha subunit 9 | -6.96 | N/A | N/A | 33.93% | CHEMBL3903908 |
| Zanamivir | TLR4_HUMAN | toll like receptor 4 | -6.10 | -6.36 | -7.38 | 36.44% | CHEMBL2364541 |
| Laninamivir | TLR4_HUMAN | toll like receptor 4 | -5.90 | -6.88 | -6.21 | 38.43% | CHEMBL2364541 |
| Oseltamivir | TLR4_HUMAN | toll like receptor 4 | -6.32 | -5.97 | -6.09 | 38.78% | CHEMBL2364541 |
| Peramivir | TLR4_HUMAN | toll like receptor 4 | -6.14 | -5.84 | -6.29 | 31.87% | CHEMBL3354639 |
| Baloxavir | TLR4_HUMAN | toll like receptor 4 | -8.64 | -9.01 | -8.92 | 22.88% | CHEMBL4068003 |
| Zanamivir | TNFA_HUMAN | tumor necrosis factor | -6.30 | N/A | N/A | 28.52% | CHEMBL2337619 |
| Laninamivir | TNFA_HUMAN | tumor necrosis factor | -6.23 | N/A | N/A | 28.68% | CHEMBL3805016 |
| Oseltamivir | TNFA_HUMAN | tumor necrosis factor | -6.26 | N/A | N/A | 33.95% | CHEMBL2337619 |
| Peramivir | TNFA_HUMAN | tumor necrosis factor | -6.88 | N/A | N/A | 33.92% | CHEMBL3805016 |
| Baloxavir | TNFA_HUMAN | tumor necrosis factor | -9.06 | N/A | N/A | 34.46% | CHEMBL3640331 |
| Zanamivir | TRBM_HUMAN | thrombomodulin | -7.42 | -7.28 | N/A | N/A | N/A |
| Laninamivir | TRBM_HUMAN | thrombomodulin | -6.26 | -6.59 | N/A | N/A | N/A |
| Oseltamivir | TRBM_HUMAN | thrombomodulin | -6.49 | -6.25 | N/A | N/A | N/A |
| Peramivir | TRBM_HUMAN | thrombomodulin | -7.48 | -6.54 | N/A | N/A | N/A |
| Baloxavir | TRBM_HUMAN | thrombomodulin | -7.82 | -6.98 | N/A | N/A | N/A |
| Zanamivir | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -6.67 | -6.55 | N/A | N/A | N/A |
| Laninamivir | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -6.02 | -6.21 | N/A | N/A | N/A |
| Oseltamivir | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -6.37 | -5.60 | N/A | N/A | N/A |
| Peramivir | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -7.40 | -6.92 | N/A | N/A | N/A |
| Baloxavir | TRPM4_HUMAN | transient receptor potential cation channel subfamily M member 4 | -8.38 | -7.16 | N/A | N/A | N/A |
| Zanamivir | TRPM8_FICAL | Uncharacterized protein | -7.25 | N/A | N/A | N/A | N/A |
| Laninamivir | TRPM8_FICAL | Uncharacterized protein | -7.20 | N/A | N/A | N/A | N/A |
| Oseltamivir | TRPM8_FICAL | Uncharacterized protein | -7.64 | N/A | N/A | N/A | N/A |
| Peramivir | TRPM8_FICAL | Uncharacterized protein | -7.51 | N/A | N/A | N/A | N/A |
| Baloxavir | TRPM8_FICAL | Uncharacterized protein | -10.09 | N/A | N/A | N/A | N/A |
| Zanamivir | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -6.07 | N/A | N/A | 32.03% | CHEMBL500075 |
| Laninamivir | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -6.07 | N/A | N/A | 32.45% | CHEMBL500075 |
| Oseltamivir | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -6.74 | N/A | N/A | 38.46% | CHEMBL97968 |
| Peramivir | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -6.82 | N/A | N/A | 33.09% | CHEMBL430173 |
| Baloxavir | TRPV1_RAT | Transient receptor potential cation channel subfamily V member 1 | -7.72 | N/A | N/A | 30.72% | CHEMBL3326588 |
| Zanamivir | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -6.73 | -6.73 | N/A | N/A | N/A |
| Laninamivir | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.53 | -7.67 | N/A | N/A | N/A |
| Oseltamivir | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -7.03 | -6.60 | N/A | N/A | N/A |
| Peramivir | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -6.72 | -8.67 | N/A | N/A | N/A |
| Baloxavir | TRPV2_RABIT | Transient receptor potential cation channel subfamily V member 2 | -8.74 | -7.10 | N/A | N/A | N/A |
| Zanamivir | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -5.34 | -6.30 | N/A | 21.40% | CHEMBL3696428 |
| Laninamivir | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -5.07 | -5.91 | N/A | 22.14% | CHEMBL3696433 |
| Oseltamivir | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -5.90 | -6.46 | N/A | 23.83% | CHEMBL3664218 |
| Peramivir | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -5.62 | -6.44 | N/A | 22.64% | CHEMBL73188 |
| Baloxavir | TRPV3_HUMAN | transient receptor potential cation channel subfamily V member 3 | -7.76 | -6.39 | N/A | 30.34% | CHEMBL3696422 |
| Zanamivir | TRXR1_HUMAN | thioredoxin reductase 1 | -6.88 | -6.38 | -5.70 | N/A | N/A |
| Laninamivir | TRXR1_HUMAN | thioredoxin reductase 1 | -6.88 | -6.06 | -5.22 | N/A | N/A |
| Oseltamivir | TRXR1_HUMAN | thioredoxin reductase 1 | -6.50 | -7.07 | -5.37 | N/A | N/A |
| Peramivir | TRXR1_HUMAN | thioredoxin reductase 1 | -6.69 | -6.54 | -5.75 | N/A | N/A |
| Baloxavir | TRXR1_HUMAN | thioredoxin reductase 1 | -10.09 | -9.32 | -8.05 | N/A | N/A |
| Zanamivir | TRY1_HUMAN | serine protease 1 | -5.35 | N/A | N/A | 32.99% | CHEMBL141574 |
| Laninamivir | TRY1_HUMAN | serine protease 1 | -5.44 | N/A | N/A | 38.31% | CHEMBL112726 |
| Oseltamivir | TRY1_HUMAN | serine protease 1 | -5.36 | N/A | N/A | 40.54% | CHEMBL141574 |
| Peramivir | TRY1_HUMAN | serine protease 1 | -6.71 | N/A | N/A | 61.86% | CHEMBL312647 |
| Baloxavir | TRY1_HUMAN | serine protease 1 | -6.84 | N/A | N/A | 30.43% | CHEMBL117092 |